Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
I-MAB (IMAB)
NASDAQ:IMAB
I-MAB (IMAB) Stock Price & Analysis
133 Followers
IMAB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.17 - $7.67
Previous Close$1.2
Volume665.76K
Average Volume (3M)601.98K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)¥3.34B
Total Debt (Recent Filing)¥10.87M
Price to Earnings (P/E)-0.3
Beta1.15
Next Earnings
Mar 27, 2024EPS Estimate
-$0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.46
Shares Outstanding82,991,269
10 Day Avg. Volume1,241,052
30 Day Avg. Volume601,976
Standard Deviation0.23
R-Squared0.06
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.04
Price to Sales (P/S)-0.45
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$21.50Price Target Upside1691.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
I-MAB News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IMAB FAQ
What was I-MAB’s price range in the past 12 months?
I-MAB lowest stock price was $1.17 and its highest was $7.67 in the past 12 months.
What is I-MAB’s market cap?
Currently, no data Available
When is I-MAB’s upcoming earnings report date?
I-MAB’s upcoming earnings report date is Mar 27, 2024 which is in 185 days.
How were I-MAB’s earnings last quarter?
I-MAB released its earnings results on Aug 17, 2023. The company reported -$0.556 earnings per share for the quarter, beating the consensus estimate of -$1.31 by $0.754.
Is I-MAB overvalued?
According to Wall Street analysts I-MAB’s price is currently Undervalued.
Does I-MAB pay dividends?
I-MAB does not currently pay dividends.
What is I-MAB’s EPS estimate?
I-MAB’s EPS estimate is -$0.65.
How many shares outstanding does I-MAB have?
I-MAB has 83,439,740 shares outstanding.
What happened to I-MAB’s price movement after its last earnings report?
I-MAB reported an EPS of -$0.556 in its last earnings report, beating expectations of -$1.31. Following the earnings report the stock price went down -2.954%.
Which hedge fund is a major shareholder of I-MAB?
Among the largest hedge funds holding I-MAB’s share is Caxton Associates LP. It holds I-MAB’s shares valued at 75K.
---
I-MAB Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.50 (1691.67% Upside)
$21.50 (1691.67% Upside)
Blogger Sentiment
Bullish
IMAB Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 179.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-74.30%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-35.17%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
I-MAB
I-Mab is a clinical stage biopharmaceutical company. It engages in discovering, developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China.
---
Top 5 ETFs holding IMAB
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold IMAB. The ETFs are listed according to market value of IMAB within the ETF
---